14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 01, 2024 Buy 72 000 Mcclure Matthew W. Stock Option (Right to Buy)
Mar 01, 2024 Buy 308 940 Calhoun Lesley Ann Stock Option (Right to Buy)
Mar 01, 2024 Buy 72 000 Symons Julian A. Stock Option (Right to Buy)
Mar 01, 2024 Buy 965 435 Blatt Lawrence Stock Option (Right to Buy)
Feb 28, 2024 Buy 4 411 Hirth Peter Stock Option (Right to Buy)
Feb 28, 2024 Buy 8 823 Scopa James Paul Stock Option (Right to Buy)
Feb 28, 2024 Buy 75 183 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 28, 2024 Buy 65 713 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 28, 2024 Buy 16 428 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 28, 2024 Buy 74 998 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 28, 2024 Buy 51 833 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 28, 2024 Buy 18 750 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 28, 2024 Buy 230 999 Blatt Lawrence Stock Option (Right to Buy)
Feb 28, 2024 Buy 132 352 Blatt Lawrence Stock Option (Right to Buy)
Feb 28, 2024 Buy 57 749 Blatt Lawrence Stock Option (Right to Buy)
Feb 28, 2024 Buy 74 998 Symons Julian A. Stock Option (Right to Buy)
Feb 28, 2024 Buy 58 822 Symons Julian A. Stock Option (Right to Buy)
Feb 28, 2024 Buy 18 750 Symons Julian A. Stock Option (Right to Buy)
Feb 28, 2024 Buy 4 411 Nielsen Jack Stock Option (Right to Buy)
Feb 28, 2024 Buy 4 411 Nuechterlein Carole Stock Option (Right to Buy)
Feb 28, 2024 Buy 8 823 Martell Bridget A Stock Option (Right to Buy)
Feb 27, 2024 Sell 15 000 Hirth Peter Stock Option (Right to Buy)
Feb 27, 2024 Sell 30 000 Scopa James Paul Stock Option (Right to Buy)
Feb 27, 2024 Sell 255 626 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 27, 2024 Sell 23 000 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 27, 2024 Sell 176 237 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 27, 2024 Sell 26 250 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 27, 2024 Sell 80 850 Blatt Lawrence Stock Option (Right to Buy)
Feb 27, 2024 Sell 450 000 Blatt Lawrence Stock Option (Right to Buy)
Feb 27, 2024 Sell 200 000 Symons Julian A. Stock Option (Right to Buy)
Feb 27, 2024 Sell 26 250 Symons Julian A. Stock Option (Right to Buy)
Feb 27, 2024 Sell 15 000 Nielsen Jack Stock Option (Right to Buy)
Feb 27, 2024 Sell 15 000 Nuechterlein Carole Stock Option (Right to Buy)
Feb 27, 2024 Sell 30 000 Martell Bridget A Stock Option (Right to Buy)
Oct 25, 2023 Buy 0 Roche Holding Ltd Common Stock, par value $0.0001 per share
Oct 25, 2023 Buy 3 966 800 Roche Holding Ltd Warrant (Right to Buy)
Oct 25, 2023 Buy 7 933 601 Nuechterlein Carole Common Stock
Oct 25, 2023 Buy 3 966 800 Nuechterlein Carole Warrant (Right to Buy)
Oct 25, 2023 Buy 610 277 Blatt Lawrence Common Stock
Oct 25, 2023 Buy 305 138 Blatt Lawrence Warrants (Right to Buy)
Oct 25, 2023 Buy 183 083 Scopa James Paul Common Stock
Oct 25, 2023 Buy 91 541 Scopa James Paul Warrant (Right to Buy)
Sep 08, 2023 Buy 48 000 Mcclure Matthew W. Stock Option (Right to Buy)
Sep 08, 2023 Buy 48 000 Calhoun Lesley Ann Stock Option (Right to Buy)
Sep 08, 2023 Buy 48 000 Quan Lucinda Y. Stock Option (Right to Buy)
Sep 08, 2023 Buy 48 000 Symons Julian A. Stock Option (Right to Buy)
Sep 08, 2023 Buy 150 000 Blatt Lawrence Stock Option (Right to Buy)
Jul 20, 2023 Buy 20 000 Martell Bridget A Stock Option (Right to Buy)
Jul 20, 2023 Buy 20 000 Nielsen Jack Stock Option (Right to Buy)
Jul 20, 2023 Buy 20 000 Hirth Peter Stock Option (Right to Buy)
Jul 20, 2023 Buy 20 000 Scopa James Paul Stock Option (Right to Buy)
Jul 20, 2023 Buy 20 000 Nuechterlein Carole Stock Option (Right to Buy)
Mar 15, 2023 Buy 75 000 Mcclure Matthew W. Stock Option (Right to Buy)
Mar 15, 2023 Buy 78 750 Symons Julian A. Stock Option (Right to Buy)
Mar 15, 2023 Buy 78 750 Calhoun Lesley Ann Stock Option (Right to Buy)
Mar 15, 2023 Buy 78 750 Quan Lucinda Y. Stock Option (Right to Buy)
Mar 15, 2023 Buy 169 500 Beigelman Leonid Stock Option (Right to Buy)
Mar 15, 2023 Buy 242 500 Blatt Lawrence Stock Option (Right to Buy)
Jul 07, 2022 Buy 46 000 Mcclure Matthew W. Stock Option (Right to Buy)
Jul 07, 2022 Buy 52 500 Quan Lucinda Y. Stock Option (Right to Buy)
Jul 07, 2022 Buy 52 500 Quan Lucinda Y. Stock Option (Right to Buy)
Jul 07, 2022 Buy 52 500 Calhoun Lesley Ann Stock Option (Right to Buy)
Jul 07, 2022 Buy 52 500 Calhoun Lesley Ann Stock Option (Right to Buy)
Jul 07, 2022 Buy 113 000 Beigelman Leonid Stock Option (Right to Buy)
Jul 07, 2022 Buy 113 000 Beigelman Leonid Stock Option (Right to Buy)
Jul 07, 2022 Buy 161 700 Blatt Lawrence Stock Option (Right to Buy)
Jul 07, 2022 Buy 161 700 Blatt Lawrence Stock Option (Right to Buy)
Jul 07, 2022 Buy 50 000 Symons Julian A. Stock Option (Right to Buy)
Jul 07, 2022 Buy 50 000 Symons Julian A. Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Woiwode Thomas Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Woiwode Thomas Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Hirth Peter Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Scopa James Paul Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Scopa James Paul Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Nielsen Jack Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Nuechterlein Carole Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Nuechterlein Carole Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Martell Bridget A Stock Option (Right to Buy)
Jun 23, 2022 Buy 15 000 Martell Bridget A Stock Option (Right to Buy)
Apr 27, 2022 Buy 0 Mcclure Matthew W. Common Stock
Apr 27, 2022 Buy 255 626 Mcclure Matthew W. Stock Option (Right to Buy)
Apr 27, 2022 Buy 53 648 Mcclure Matthew W. Stock Option (Right to Buy)
Apr 27, 2022 Buy 23 000 Mcclure Matthew W. Stock Option (Right to Buy)
Feb 04, 2022 Buy 105 000 Symons Julian A. Stock Option (Right to Buy)
Feb 04, 2022 Buy 26 250 Symons Julian A. Stock Option (Right to Buy)
Feb 04, 2022 Buy 323 400 Blatt Lawrence Stock Option (Right to Buy)
Feb 04, 2022 Buy 80 850 Blatt Lawrence Stock Option (Right to Buy)
Feb 04, 2022 Buy 105 000 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 04, 2022 Buy 26 250 Calhoun Lesley Ann Stock Option (Right to Buy)
Feb 04, 2022 Buy 105 000 Quan Lucinda Y. Stock Option (Right to Buy)
Feb 04, 2022 Buy 105 000 Quan Lucinda Y. Stock Option (Right to Buy)
Feb 04, 2022 Buy 26 250 Quan Lucinda Y. Stock Option (Right to Buy)
Feb 04, 2022 Buy 26 250 Quan Lucinda Y. Stock Option (Right to Buy)
Feb 04, 2022 Buy 226 800 Beigelman Leonid Stock Option (Right to Buy)
Feb 04, 2022 Buy 56 700 Beigelman Leonid Stock Option (Right to Buy)
Nov 16, 2021 Buy 30 000 Martell Bridget A Stock Option (Right to Buy)
Nov 16, 2021 Buy 0 Martell Bridget A
Jun 17, 2021 Buy 15 000 Nielsen Jack Stock Option (Right to Buy)
Jun 17, 2021 Buy 15 000 Woiwode Thomas Stock Option (Right to Buy)
Jun 17, 2021 Buy 15 000 Hirth Peter Stock Option (Right to Buy)
INSIDER POWER
78.069
Last 100 transactions
Buy: 23 223 743 | Sell: 1 343 213 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 78.069.

In total, the insiders bought 23 223 743 and sold 1 343 213 ALGS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Aligos Therapeutics Inc.

Aligos Therapeutics. Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The com... ALGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT